Cargando…
Identification of metabolic pathways and enzyme systems involved in the in vitro human hepatic metabolism of dronedarone, a potent new oral antiarrhythmic drug
The in vitro metabolism of dronedarone and its major metabolites has been studied in human liver microsomes and cryopreserved hepatocytes in primary culture through the use of specific or total cytochrome P450 (CYP) and monoamine oxidase (MAO) inhibitors. The identification of the main metabolites a...
Autores principales: | Klieber, Sylvie, Arabeyre-Fabre, Catherine, Moliner, Patricia, Marti, Eric, Mandray, Martine, Ngo, Robert, Ollier, Céline, Brun, Priscilla, Fabre, Gérard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186413/ https://www.ncbi.nlm.nih.gov/pubmed/25505590 http://dx.doi.org/10.1002/prp2.44 |
Ejemplares similares
-
Absorption, Metabolism, and Excretion of [(14)C]-Tolebrutinib After Oral Administration in Humans, Contribution of the Metabolites to Pharmacological Activity
por: Nicolas, Olivier, et al.
Publicado: (2023) -
Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013) -
Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics
por: Tave, Arlene, et al.
Publicado: (2021) -
Class III antiarrhythmic drugs amiodarone and dronedarone impair K(IR)2.1 backward trafficking
por: Ji, Yuan, et al.
Publicado: (2017) -
International cohort study on the effectiveness of dronedarone and other antiarrhythmic drugs for atrial fibrillation in real-world practice (EFFECT-AF)
por: Khachatryan, Artak, et al.
Publicado: (2021)